RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 36 filers reported holding RENEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,337,973 | -9.0% | 886,075 | 0.0% | 0.58% | +16.3% |
| Q1 2024 | $1,470,885 | +3.8% | 886,075 | 0.0% | 0.50% | +17.7% |
| Q4 2023 | $1,417,720 | -79.0% | 886,075 | 0.0% | 0.42% | -84.8% |
| Q3 2023 | $6,743,031 | +16.0% | 886,075 | 0.0% | 2.78% | -2.4% |
| Q2 2023 | $5,812,652 | +9.7% | 886,075 | 0.0% | 2.85% | +11.6% |
| Q1 2023 | $5,298,729 | +156.7% | 886,075 | 0.0% | 2.55% | +87.1% |
| Q4 2022 | $2,064,555 | -30.4% | 886,075 | 0.0% | 1.36% | -30.8% |
| Q3 2022 | $2,968,000 | +26.4% | 886,075 | 0.0% | 1.97% | +17.7% |
| Q2 2022 | $2,348,000 | -9.9% | 886,075 | 0.0% | 1.68% | +19.1% |
| Q1 2022 | $2,605,000 | -65.6% | 886,075 | 0.0% | 1.41% | -47.4% |
| Q4 2021 | $7,576,000 | +14.8% | 886,075 | 0.0% | 2.67% | +103.1% |
| Q3 2021 | $6,601,000 | -20.2% | 886,075 | 0.0% | 1.32% | -0.6% |
| Q2 2021 | $8,267,000 | – | 886,075 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $4,054,752 | 14.95% |
| BML Capital Management, LLC | 1,314,229 | $2,102,766 | 1.59% |
| Octagon Capital Advisors LP | 2,250,000 | $3,600,000 | 0.58% |
| NEA Management Company, LLC | 4,785,494 | $7,656,790 | 0.51% |
| TANG CAPITAL MANAGEMENT LLC | 3,330,000 | $5,328,000 | 0.49% |
| Aisling Capital Management LP | 886,075 | $1,417,720 | 0.42% |
| Carlyle Group Inc. | 2,698,957 | $4,318,331 | 0.21% |
| Ikarian Capital, LLC | 1,082,600 | $1,732,160 | 0.16% |
| FIFTH LANE CAPITAL, LP | 40,000 | $64,000 | 0.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,121,704 | $1,794,726 | 0.07% |